Cargando…

Advantages of a next generation sequencing targeted approach for the molecular diagnosis of retinoblastoma

BACKGROUND: Retinoblastoma (RB) is the most common malignant childhood tumor of the eye and results from inactivation of both alleles of the RB1 gene. Nowadays RB genetic diagnosis requires classical chromosome investigations, Multiplex Ligation-dependent Probe Amplification analysis (MLPA) and Sang...

Descripción completa

Detalles Bibliográficos
Autores principales: Grotta, Simona, D’Elia, Gemma, Scavelli, Rossana, Genovese, Silvia, Surace, Cecilia, Sirleto, Pietro, Cozza, Raffaele, Romanzo, Antonino, De Ioris, Maria Antonietta, Valente, Paola, Tomaiuolo, Anna Cristina, Lepri, Francesca Romana, Franchin, Tiziana, Ciocca, Laura, Russo, Serena, Locatelli, Franco, Angioni, Adriano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632486/
https://www.ncbi.nlm.nih.gov/pubmed/26530098
http://dx.doi.org/10.1186/s12885-015-1854-0
_version_ 1782399041871544320
author Grotta, Simona
D’Elia, Gemma
Scavelli, Rossana
Genovese, Silvia
Surace, Cecilia
Sirleto, Pietro
Cozza, Raffaele
Romanzo, Antonino
De Ioris, Maria Antonietta
Valente, Paola
Tomaiuolo, Anna Cristina
Lepri, Francesca Romana
Franchin, Tiziana
Ciocca, Laura
Russo, Serena
Locatelli, Franco
Angioni, Adriano
author_facet Grotta, Simona
D’Elia, Gemma
Scavelli, Rossana
Genovese, Silvia
Surace, Cecilia
Sirleto, Pietro
Cozza, Raffaele
Romanzo, Antonino
De Ioris, Maria Antonietta
Valente, Paola
Tomaiuolo, Anna Cristina
Lepri, Francesca Romana
Franchin, Tiziana
Ciocca, Laura
Russo, Serena
Locatelli, Franco
Angioni, Adriano
author_sort Grotta, Simona
collection PubMed
description BACKGROUND: Retinoblastoma (RB) is the most common malignant childhood tumor of the eye and results from inactivation of both alleles of the RB1 gene. Nowadays RB genetic diagnosis requires classical chromosome investigations, Multiplex Ligation-dependent Probe Amplification analysis (MLPA) and Sanger sequencing. Nevertheless, these techniques show some limitations. We report our experience on a cohort of RB patients using a combined approach of Next-Generation Sequencing (NGS) and RB1 custom array-Comparative Genomic Hybridization (aCGH). METHODS: A total of 65 patients with retinoblastoma were studied: 29 cases of bilateral RB and 36 cases of unilateral RB. All patients were previously tested with conventional cytogenetics and MLPA techniques. Fifty-three samples were then analysed using NGS. Eleven cases were analysed by RB1 custom aCGH. One last case was studied only by classic cytogenetics. Finally, it has been tested, in a lab sensitivity assay, the capability of NGS to detect artificial mosaicism series in previously recognized samples prepared at 3 different mosaicism frequencies: 10, 5, 1 %. RESULTS: Of the 29 cases of bilateral RB, 28 resulted positive (96.5 %) to the genetic investigation: 22 point mutations and 6 genomic rearrangements (four intragenic and two macrodeletion). A novel germline intragenic duplication, from exon18 to exon 23, was identified in a proband with bilateral RB. Of the 36 available cases of unilateral RB, 8 patients resulted positive (22 %) to the genetic investigation: 3 patients showed point mutations while 5 carried large deletion. Finally, we successfully validated, in a lab sensitivity assay, the capability of NGS to accurately measure level of artificial mosaicism down to 1 %. CONCLUSIONS: NGS and RB1-custom aCGH have demonstrated to be an effective combined approach in order to optimize the overall diagnostic procedures of RB. Custom aCGH is able to accurately detect genomic rearrangements allowing the characterization of their extension. NGS is extremely accurate in detecting single nucleotide variants, relatively simple to perform, cost savings and efficient and has confirmed a high sensitivity and accuracy in identifying low levels of artificial mosaicisms.
format Online
Article
Text
id pubmed-4632486
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46324862015-11-05 Advantages of a next generation sequencing targeted approach for the molecular diagnosis of retinoblastoma Grotta, Simona D’Elia, Gemma Scavelli, Rossana Genovese, Silvia Surace, Cecilia Sirleto, Pietro Cozza, Raffaele Romanzo, Antonino De Ioris, Maria Antonietta Valente, Paola Tomaiuolo, Anna Cristina Lepri, Francesca Romana Franchin, Tiziana Ciocca, Laura Russo, Serena Locatelli, Franco Angioni, Adriano BMC Cancer Research Article BACKGROUND: Retinoblastoma (RB) is the most common malignant childhood tumor of the eye and results from inactivation of both alleles of the RB1 gene. Nowadays RB genetic diagnosis requires classical chromosome investigations, Multiplex Ligation-dependent Probe Amplification analysis (MLPA) and Sanger sequencing. Nevertheless, these techniques show some limitations. We report our experience on a cohort of RB patients using a combined approach of Next-Generation Sequencing (NGS) and RB1 custom array-Comparative Genomic Hybridization (aCGH). METHODS: A total of 65 patients with retinoblastoma were studied: 29 cases of bilateral RB and 36 cases of unilateral RB. All patients were previously tested with conventional cytogenetics and MLPA techniques. Fifty-three samples were then analysed using NGS. Eleven cases were analysed by RB1 custom aCGH. One last case was studied only by classic cytogenetics. Finally, it has been tested, in a lab sensitivity assay, the capability of NGS to detect artificial mosaicism series in previously recognized samples prepared at 3 different mosaicism frequencies: 10, 5, 1 %. RESULTS: Of the 29 cases of bilateral RB, 28 resulted positive (96.5 %) to the genetic investigation: 22 point mutations and 6 genomic rearrangements (four intragenic and two macrodeletion). A novel germline intragenic duplication, from exon18 to exon 23, was identified in a proband with bilateral RB. Of the 36 available cases of unilateral RB, 8 patients resulted positive (22 %) to the genetic investigation: 3 patients showed point mutations while 5 carried large deletion. Finally, we successfully validated, in a lab sensitivity assay, the capability of NGS to accurately measure level of artificial mosaicism down to 1 %. CONCLUSIONS: NGS and RB1-custom aCGH have demonstrated to be an effective combined approach in order to optimize the overall diagnostic procedures of RB. Custom aCGH is able to accurately detect genomic rearrangements allowing the characterization of their extension. NGS is extremely accurate in detecting single nucleotide variants, relatively simple to perform, cost savings and efficient and has confirmed a high sensitivity and accuracy in identifying low levels of artificial mosaicisms. BioMed Central 2015-11-04 /pmc/articles/PMC4632486/ /pubmed/26530098 http://dx.doi.org/10.1186/s12885-015-1854-0 Text en © Grotta et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Grotta, Simona
D’Elia, Gemma
Scavelli, Rossana
Genovese, Silvia
Surace, Cecilia
Sirleto, Pietro
Cozza, Raffaele
Romanzo, Antonino
De Ioris, Maria Antonietta
Valente, Paola
Tomaiuolo, Anna Cristina
Lepri, Francesca Romana
Franchin, Tiziana
Ciocca, Laura
Russo, Serena
Locatelli, Franco
Angioni, Adriano
Advantages of a next generation sequencing targeted approach for the molecular diagnosis of retinoblastoma
title Advantages of a next generation sequencing targeted approach for the molecular diagnosis of retinoblastoma
title_full Advantages of a next generation sequencing targeted approach for the molecular diagnosis of retinoblastoma
title_fullStr Advantages of a next generation sequencing targeted approach for the molecular diagnosis of retinoblastoma
title_full_unstemmed Advantages of a next generation sequencing targeted approach for the molecular diagnosis of retinoblastoma
title_short Advantages of a next generation sequencing targeted approach for the molecular diagnosis of retinoblastoma
title_sort advantages of a next generation sequencing targeted approach for the molecular diagnosis of retinoblastoma
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632486/
https://www.ncbi.nlm.nih.gov/pubmed/26530098
http://dx.doi.org/10.1186/s12885-015-1854-0
work_keys_str_mv AT grottasimona advantagesofanextgenerationsequencingtargetedapproachforthemoleculardiagnosisofretinoblastoma
AT deliagemma advantagesofanextgenerationsequencingtargetedapproachforthemoleculardiagnosisofretinoblastoma
AT scavellirossana advantagesofanextgenerationsequencingtargetedapproachforthemoleculardiagnosisofretinoblastoma
AT genovesesilvia advantagesofanextgenerationsequencingtargetedapproachforthemoleculardiagnosisofretinoblastoma
AT suracececilia advantagesofanextgenerationsequencingtargetedapproachforthemoleculardiagnosisofretinoblastoma
AT sirletopietro advantagesofanextgenerationsequencingtargetedapproachforthemoleculardiagnosisofretinoblastoma
AT cozzaraffaele advantagesofanextgenerationsequencingtargetedapproachforthemoleculardiagnosisofretinoblastoma
AT romanzoantonino advantagesofanextgenerationsequencingtargetedapproachforthemoleculardiagnosisofretinoblastoma
AT deiorismariaantonietta advantagesofanextgenerationsequencingtargetedapproachforthemoleculardiagnosisofretinoblastoma
AT valentepaola advantagesofanextgenerationsequencingtargetedapproachforthemoleculardiagnosisofretinoblastoma
AT tomaiuoloannacristina advantagesofanextgenerationsequencingtargetedapproachforthemoleculardiagnosisofretinoblastoma
AT leprifrancescaromana advantagesofanextgenerationsequencingtargetedapproachforthemoleculardiagnosisofretinoblastoma
AT franchintiziana advantagesofanextgenerationsequencingtargetedapproachforthemoleculardiagnosisofretinoblastoma
AT cioccalaura advantagesofanextgenerationsequencingtargetedapproachforthemoleculardiagnosisofretinoblastoma
AT russoserena advantagesofanextgenerationsequencingtargetedapproachforthemoleculardiagnosisofretinoblastoma
AT locatellifranco advantagesofanextgenerationsequencingtargetedapproachforthemoleculardiagnosisofretinoblastoma
AT angioniadriano advantagesofanextgenerationsequencingtargetedapproachforthemoleculardiagnosisofretinoblastoma